| EX-10.10 - AMENDMENT NO. 2 TO DRUG LICENSE AND DEVELOPMENT AGREEMENT WITH ONCOLOGY VENTURE - Lantern Pharma Inc. | ea120601fs1ex10-10_lantern.htm |
| S-1 - REGISTRATION STATEMENT - Lantern Pharma Inc. | ea120601-s1_lanternpharma.htm |
| EX-23.1 - CONSENT OF EISNERAMPER LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Lantern Pharma Inc. | ea120601fs1ex23-1_lantern.htm |
| EX-14.1 - CODE OF BUSINESS CONDUCT AND ETHICS - Lantern Pharma Inc. | ea120601fs1ex14-1_lantern.htm |
| EX-10.12 - ADDENDUM TO TECHNOLOGYLICENSE AGREEMENT DATED FEBRUARY 8, 2016, WITH AF CHEMICAL - Lantern Pharma Inc. | ea120601fs1ex10-12_lantern.htm |
| EX-10.11 - ASSIGNMENT AGREEMENTDATED AS OF JANUARY 5, 2018 WITH BIONUMERIK PHARMACEUTICALS, - Lantern Pharma Inc. | ea120601fs1ex10-11_lantern.htm |
| EX-10.9 - ADDENDUM TO DRUG LICENSE AND DEVELOPMENT AGREEMENT WITH ONCOLOGY VENTURE A/S DAT - Lantern Pharma Inc. | ea120601fs1ex10-9_lantern.htm |
| EX-10.8 - DRUG LICENSE AND DEVELOPMENT AGREEMENT DATED AS OF MAY 23, 2015 WITH ONCOLOGY VE - Lantern Pharma Inc. | ea120601fs1ex10-8_lantern.htm |
| EX-10.7 - TECHNOLOGY LICENSE AGREEMENT DATED JANUARY 15,2015, WITH AF CHEMICALS LLC - Lantern Pharma Inc. | ea120601fs1ex10-7_lantern.htm |
| EX-10.6 - AMENDED AND RESTATED VOTING AGREEMENT - Lantern Pharma Inc. | ea120601fs1ex10-6_lantern.htm |
| EX-10.5 - AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT - Lantern Pharma Inc. | ea120601fs1ex10-5_lantern.htm |
| EX-10.4 - AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT - Lantern Pharma Inc. | ea120601fs1ex10-4_lantern.htm |
| EX-10.3 - FORM OF INDEMNIFICATION AGREEMENT - Lantern Pharma Inc. | ea120601fs1ex10-3_lantern.htm |
| EX-10.2 - EMPLOYMENT AGREEMENT DATED JULY 23, 2018 WITH PANNA SHARMA - Lantern Pharma Inc. | ea120601fs1ex10-2_lantern.htm |
| EX-10.1 - AMENDED AND RESTATED 2018 EQUITY INCENTIVE PLAN - Lantern Pharma Inc. | ea120601fs1ex10-1_lantern.htm |
| EX-4.1(III) - FORM OF WARRANT (2019) - Lantern Pharma Inc. | ea120601fs1ex4-1iii_lantern.htm |
| EX-4.1(II) - FORM OF WARRANT (2017) - Lantern Pharma Inc. | ea120601fs1ex4-1ii_lantern.htm |
| EX-4.1(I) - FORM OF WARRANT (2014) - Lantern Pharma Inc. | ea120601fs1ex4-1i_lantern.htm |
| EX-3.1(IV) - BYLAWS - Lantern Pharma Inc. | ea120601fs1ex3-1iv_lantern.htm |
| EX-3.1(III) - CERTIFICATE OF INCORPORATION - Lantern Pharma Inc. | ea120601fs1ex3-1iii_lantern.htm |
| EX-3.1(II) - CERTIFICATE OF CONVERSION (DELAWARE) - Lantern Pharma Inc. | ea120601fs1ex3-1ii_lantern.htm |
| EX-3.1(I) - CERTIFICATE OF CONVERSION (TEXAS) - Lantern Pharma Inc. | ea120601fs1ex3-1i_lantern.htm |
